Stockscreener 앱 받기
13.76
1.43%
-0.27
전일 마감가:
$14.03
열려 있는:
$14.05
하루 거래량:
68,836
Relative Volume:
0.23
시가총액:
$257.05M
수익:
$62.81M
순이익/손실:
$-13.75M
주가수익비율:
-17.20
EPS:
-0.8
순현금흐름:
$153.00K
1주 성능:
-2.88%
1개월 성능:
-14.37%
6개월 성능:
-8.11%
1년 성능:
+180.53%
1일 변동 폭
$13.68
$14.25
1주일 범위
$13.13
$14.64
52주 변동 폭
$3.9914
$22.25
Optimizerx Corp Stock (OPRX) Company Profile
명칭
Optimizerx Corp
전화
248-651-6558
주소
260 CHARLES STREET, WALTHAM, MI
OPRX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
OPRX
Optimizerx Corp
|
13.79 | 261.53M | 62.81M | -13.75M | 153.00K | -0.80 |
|
VEEV
Veeva Systems Inc
|
223.37 | 37.72B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
TEM
Tempus Ai Inc
|
71.58 | 13.14B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
HQY
Healthequity Inc
|
97.33 | 8.32B | 1.15B | 96.70M | -161.99M | 1.09 |
|
DOCS
Doximity Inc
|
43.93 | 8.31B | 550.17M | 201.35M | 232.07M | 1.00 |
|
BTSG
Brightspring Health Services Inc
|
36.80 | 6.47B | 11.99B | 24.18M | 234.31M | 0.2956 |
Optimizerx Corp Stock (OPRX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-01-08 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2024-12-20 | 개시 | Stephens | Equal-Weight |
| 2024-07-25 | 재개 | B. Riley Securities | Buy |
| 2024-04-04 | 개시 | JMP Securities | Mkt Outperform |
| 2024-01-03 | 개시 | Barclays | Equal Weight |
| 2023-02-02 | 재개 | B. Riley Securities | Buy |
| 2022-11-01 | 개시 | Stifel | Buy |
| 2022-07-15 | 개시 | SVB Leerink | Outperform |
| 2021-10-18 | 재개 | B. Riley Securities | Buy |
| 2021-04-13 | 개시 | RBC Capital Mkts | Outperform |
| 2019-01-03 | 개시 | William Blair | Outperform |
모두보기
Optimizerx Corp 주식(OPRX)의 최신 뉴스
Looking at the Narrative for OptimizeRx After Guidance Boost and Recurring Revenue Shift - Yahoo Finance
OptimizeRx (NASDAQ:OPRX) Cut to “Buy” at Wall Street Zen - Defense World
OptimizeRx downgraded to "sector perform" by RBC amid slower growth outlook - MSN
Financial Comparison: OptimizeRx (NASDAQ:OPRX) and SS&C Technologies (NASDAQ:SSNC) - Defense World
OptimizeRx Corporation (OPRX) Analyst insights, Price targets and Recommendations - Yahoo Finance UK
How Recent Developments Are Shaping the OptimizeRx Investment Story - Yahoo Finance
OptimizeRx Corp. (NASDAQ:OPRX) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
OptimizeRx Corp. (NASDAQ:OPRX) Receives Average Rating of “Moderate Buy” from Brokerages - Defense World
Connor Clark & Lunn Investment Management Ltd. Makes New Investment in OptimizeRx Corp. $OPRX - MarketBeat
Is OptimizeRx Corporation stock attractive for growth ETFs2025 Bull vs Bear & Daily Growth Stock Investment Tips - newser.com
P.A.W. Capital Corp Invests $675,000 in OptimizeRx Corp. $OPRX - MarketBeat
Can OptimizeRx Corporation stock deliver surprise earnings beat2025 Bull vs Bear & Verified Entry Point Detection - newser.com
Is a relief rally coming for OptimizeRx Corporation holdersInsider Selling & Fast Gain Swing Alerts - newser.com
OptimizeRx (OPRX) Price Target Increased by 24.79% to 24.82 - MSN
Can OptimizeRx Corporation stock sustain market leadershipJuly 2025 Update & Technical Pattern Alert System - newser.com
Automated trading signals detected on OptimizeRx CorporationJuly 2025 WrapUp & Reliable Entry Point Trade Alerts - newser.com
OptimizeRx CorporationCommon Stock (NQ: OPRX - Markets Financial Content
Stephens Issues Pessimistic Forecast for OptimizeRx (NASDAQ:OPRX) Stock Price - MarketBeat
OptimizeRx : Corporate PresentationNovember 2025 - MarketScreener
How OptimizeRx Corporation stock performs in rate cut cyclesJuly 2025 Pullbacks & AI Optimized Trading Strategy Guides - newser.com
OptimizeRx (OPRX) Analyst Rating Update: Stephens & Co. Lowers P - GuruFocus
Los Angeles Capital Management LLC Makes New $349,000 Investment in OptimizeRx Corp. $OPRX - MarketBeat
When is the best time to exit OptimizeRx Corporation2025 Market Sentiment & Safe Entry Zone Tips - newser.com
Published on: 2025-11-16 12:30:34 - newser.com
Will OptimizeRx Corporation stock maintain momentum in 20252025 Valuation Update & AI Powered Market Trend Analysis - newser.com
Brendan W. Merrell Net Worth (2025) - GuruFocus
COO Merrell Surrenders 483 Of OptimizeRx Corp [OPRX] - TradingView
[Form 4] OptimizeRx Corp Insider Trading Activity - Stock Titan
Can a trend reversal in OptimizeRx Corporation lead to recoveryJuly 2025 Outlook & Reliable Intraday Trade Plans - newser.com
[Form 3] OptimizeRx Corp Initial Statement of Beneficial Ownership - Stock Titan
OptimizeRx (OPRX) Q3 2025 Earnings Call Transcript - Yahoo Finance
OptimizeRx (NASDAQ:OPRX) Issues Earnings Results, Beats Expectations By $0.17 EPS - MarketBeat
OptimizeRx (NASDAQ:OPRX) Raised to Strong-Buy at Wall Street Zen - MarketBeat
ETFs Investing in OptimizeRx Corporation Stocks - TradingView
OptimizeRx Corporation (NASDAQ:OPRX) Q3 2025 Earnings Call Transcript - Insider Monkey
Citizens Maintains OptimizeRx (OPRX) Market Outperform Recommendation - MSN
OptimizeRx (NASDAQ:OPRX) Stock Price Expected to Rise, Citizens Jmp Analyst Says - MarketBeat
How Recent Upgrades Are Changing the OptimizeRx Story According to Analysts - Yahoo Finance
OptimizeRx Corp. (OPRX) Tops Q3 Earnings and Revenue Estimates - sharewise.com
OptimizeRx Delivers Big Earnings Beat And Raises Outlook Again - Finimize
[10-Q] OptimizeRx Corp Quarterly Earnings Report | OPRX SEC FilingForm 10-Q - Stock Titan
Optimizerx Corp (OPRX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Optimizerx Corp 주식 (OPRX) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Silvestro Stephen L | Chief Executive Officer |
Oct 03 '25 |
Option Exercise |
0.00 |
6,649 |
0 |
190,536 |
| Silvestro Stephen L | Chief Executive Officer |
Oct 03 '25 |
Sale |
18.75 |
1,620 |
30,375 |
188,916 |
| Stelmakh Edward | Chief Finance & Strat Officer |
Oct 03 '25 |
Option Exercise |
0.00 |
16,623 |
0 |
127,387 |
| Besch Doug | Chief Product & Tech Officer |
Oct 03 '25 |
Option Exercise |
0.00 |
3,325 |
0 |
70,555 |
| Spangler Patrick D | Director |
Aug 28 '25 |
Sale |
17.49 |
11,120 |
194,489 |
44,215 |
5.08%
0.10%
자본화:
|
볼륨(24시간):